Search research articles
Contact Us
Filters
Showing results (261-270 of 635) with videos related to
Page
of 64
Sort By:
American Heart Journal
|
May 16, 2016
Design and rationale for the Effects of Ticagrelor and Clopidogrel in Patients with Peripheral Artery Disease (EUCLID) trial
Jeffrey S Berger, Brian G Katona, W Schuyler Jones, et al.
The New England Journal of Medicine
|
June 28, 2002
Troponin T levels in patients with acute coronary syndromes, with or without renal dysfunction
Ronnier J Aviles, Arman T Askari, Bertil Lindahl, et al.
Diabetologia
|
August 27, 2021
Effects of canagliflozin compared with placebo on major adverse cardiovascular and kidney events in patient groups with different baseline levels of HbA<sub>1c</sub>, disease duration and treatment intensity: results from the CANVAS Program
Tamara K Young, Jing-Wei Li, Amy Kang, et al.
The American Journal of Medicine
|
December 6, 2003
Prognostic importance of new small Q waves following non-ST-elevation acute coronary syndromes
John H Alexander, Robert A Harrington, Manju Bhapkar, et al.
International Journal of Cardiology
|
December 5, 2013
Review of the accumulated PLATO documentation supports reliable and consistent superiority of ticagrelor over clopidogrel in patients with acute coronary syndrome: Commentary on: DiNicolantonio JJ, Tomek A, Inactivations, deletions, non-adjudications, and downgrades of clinical endpoints on ticagrelor: serious concerns over the reliability of the PLATO trial, International Journal of Cardiology, 2013
Lars Wallentin, Richard C Becker, Christopher P Cannon, et al.
Circulation. Genomic and Precision Medicine
|
April 11, 2023
Accelerated Epigenetic Aging Is Associated With Multiple Cardiometabolic, Hematologic, and Renal Abnormalities: A Project Baseline Health Substudy
Best Uchehara, Lydia Coulter Kwee, Jessica Regan, et al.
Clinical Journal of the American Society of Nephrology : CJASN
|
July 14, 2025
SGLT2 Inhibition and Hospitalizations in Patients with CKD: A Meta-Analysis of Kidney Outcome Trials
Megumi Oshima, Luke Buizen, Niels Jongs, et al.
Journal of the American Heart Association
|
January 19, 2024
Primary and Secondary Cardiovascular and Kidney Prevention With Canagliflozin: Insights From the CANVAS Program and CREDENCE Trial
Abhinav Sharma, Amir Razaghizad, Abdulaziz Joury, et al.
American Heart Journal
|
June 20, 2017
Factors associated with non-vitamin K antagonist oral anticoagulants for stroke prevention in patients with new-onset atrial fibrillation: Results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation II (ORBIT-AF II)
Benjamin A Steinberg, Peter Shrader, Laine Thomas, et al.
Circulation. Cardiovascular Interventions
|
January 1, 2017
Impact of Cerebrovascular Events Older Than One Year on Ischemic and Bleeding Outcomes With Cangrelor in Percutaneous Coronary Intervention
Neal N Sawlani, Robert A Harrington, Gregg W Stone, et al.
Page
of 64
Search research articles
Search
Showing results (261-270 of 635) with videos related to
Sort By:
Page
of 64
American Heart Journal
|
May 16, 2016
Design and rationale for the Effects of Ticagrelor and Clopidogrel in Patients with Peripheral Artery Disease (EUCLID) trial
Jeffrey S Berger, Brian G Katona, W Schuyler Jones, et al.
The New England Journal of Medicine
|
June 28, 2002
Troponin T levels in patients with acute coronary syndromes, with or without renal dysfunction
Ronnier J Aviles, Arman T Askari, Bertil Lindahl, et al.
Diabetologia
|
August 27, 2021
Effects of canagliflozin compared with placebo on major adverse cardiovascular and kidney events in patient groups with different baseline levels of HbA<sub>1c</sub>, disease duration and treatment intensity: results from the CANVAS Program
Tamara K Young, Jing-Wei Li, Amy Kang, et al.
The American Journal of Medicine
|
December 6, 2003
Prognostic importance of new small Q waves following non-ST-elevation acute coronary syndromes
John H Alexander, Robert A Harrington, Manju Bhapkar, et al.
International Journal of Cardiology
|
December 5, 2013
Review of the accumulated PLATO documentation supports reliable and consistent superiority of ticagrelor over clopidogrel in patients with acute coronary syndrome: Commentary on: DiNicolantonio JJ, Tomek A, Inactivations, deletions, non-adjudications, and downgrades of clinical endpoints on ticagrelor: serious concerns over the reliability of the PLATO trial, International Journal of Cardiology, 2013
Lars Wallentin, Richard C Becker, Christopher P Cannon, et al.
Circulation. Genomic and Precision Medicine
|
April 11, 2023
Accelerated Epigenetic Aging Is Associated With Multiple Cardiometabolic, Hematologic, and Renal Abnormalities: A Project Baseline Health Substudy
Best Uchehara, Lydia Coulter Kwee, Jessica Regan, et al.
Clinical Journal of the American Society of Nephrology : CJASN
|
July 14, 2025
SGLT2 Inhibition and Hospitalizations in Patients with CKD: A Meta-Analysis of Kidney Outcome Trials
Megumi Oshima, Luke Buizen, Niels Jongs, et al.
Journal of the American Heart Association
|
January 19, 2024
Primary and Secondary Cardiovascular and Kidney Prevention With Canagliflozin: Insights From the CANVAS Program and CREDENCE Trial
Abhinav Sharma, Amir Razaghizad, Abdulaziz Joury, et al.
American Heart Journal
|
June 20, 2017
Factors associated with non-vitamin K antagonist oral anticoagulants for stroke prevention in patients with new-onset atrial fibrillation: Results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation II (ORBIT-AF II)
Benjamin A Steinberg, Peter Shrader, Laine Thomas, et al.
Circulation. Cardiovascular Interventions
|
January 1, 2017
Impact of Cerebrovascular Events Older Than One Year on Ischemic and Bleeding Outcomes With Cangrelor in Percutaneous Coronary Intervention
Neal N Sawlani, Robert A Harrington, Gregg W Stone, et al.
Page
of 64